Will Basta
— Investor
Backing the Companies Transforming Human Health
Will Basta is a US-based investor with a focused thesis: the most important and most investable transformation happening right now is in human health and longevity.
William Basta deploys capital into the companies, founders, and technologies that are not just improving healthcare — they are rebuilding it from the ground up.
"The conventional healthcare system is reactive by design."
It waits for disease and then responds to it.
Will Basta invests in the opposite — companies building proactive, personalized, biology-first systems that optimize human health before problems occur and extend the years in which people perform at their highest level.
This is not a trend. It is a fundamental shift in how humanity will relate to its own biology. And it is happening now.
Five Areas of
Active Investment
Stem Cell & Regenerative Medicine
Will Basta backs companies advancing the clinical application of stem cell therapy — moving regenerative treatments from research into real, scalable patient outcomes.
Peptide Science & Biological Optimization
The peptide space represents one of the most promising frontiers in personalized medicine. Will Basta follows this space closely and invests in companies bringing rigorous science to biological optimization.
Biopharmaceuticals
Next-generation drug development — targeted, precise, and built around individual biology rather than population averages.
Personalized & Functional Medicine
Data-driven, individualized health protocols. Will Basta invests in the platforms and practices making truly personalized medicine accessible at scale.
Health Technology
The infrastructure layer of the longevity revolution — the tools, platforms, and systems that make advanced health science available beyond elite clinical settings.
Where Science Meets
Exceptional Founders.
Great science is not enough. Great teams are not enough. Will Basta invests at the intersection of both — where credible, defensible science meets an exceptional founding team with the clarity and conviction to build something that lasts.
Real Scientific Foundation
Not trend-chasing, not incremental. Credible, defensible science that stands on its own.
Founder Quality
Resilience, honesty, and genuine domain expertise. The people who build what lasts.
Transformative Potential
Companies that could meaningfully change how people experience their health — not marginal improvements.
Long-Term Value Creation
Businesses built to matter, not just to exit. Durable, compounding value over time.
Not a passive
investor.
The companies he backs get access to his network, his operational experience, and his direct involvement as a strategic partner.
He has built businesses. He understands the decisions that define whether a company scales or stalls. That perspective is what he brings to every investment relationship — alongside the capital.
Leverage 1
Alongside his investment activity, Will Basta provides strategic advisory through Leverage 1 — his consulting practice for founders and executives in health, longevity, and technology.
Learn More